1.0Avalere Health Advisoryhttps://advisory.avalerehealth.comRosalie Hoyle | Avalere Health Advisoryrich600338<blockquote class="wp-embedded-content" data-secret="s6x8hKp0vM"><a href="https://advisory.avalerehealth.com/team/rosalie-hoyle">Rosalie Hoyle</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://advisory.avalerehealth.com/team/rosalie-hoyle/embed#?secret=s6x8hKp0vM" width="600" height="338" title="“Rosalie Hoyle” — Avalere Health Advisory" data-secret="s6x8hKp0vM" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
Rosalie supports clients focused on clinical development, FDA engagement and filing, and broader lifecycle management strategies for drugs, biologics and medical devices. Before joining Avalere, Rosalie conducted oncology research on drug target validation and preclinical development of small molecules. Previously, she contributed to market research and therapeutic landscape reports during her internship at ATP Ventures…